HDAC9 and chronic obstructive pulmonary disease: We also discuss the current preclinical status of pan- and isoform-selective histone deacetylase (HDAC) inhibitors, DNA methylation, and microRNA modulators and propose new research areas that may facilitate locus-specific epigenome editing as a novel therapeutic strategy for IPF and COPD.